1. Metabolic Profile of Nebivolol, a β-Adrenoceptor Antagonist with Unique Characteristics

   • Enrico Agabiti Rosei
   • Damiano Rizzoni

   Current Opinion 18 September 2012 Pages: 1097 - 1107

   

2. Hormone-Refractory Prostate Cancer

   • Giuseppe Di Lorenzo
   • Riccardo Autorino
   • Sabino De Placido

   Leading Article 18 September 2012 Pages: 1109 - 1124

   

3. Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer

   • Janet E. Dancey

   Leading Article 18 September 2012 Pages: 1125 - 1138

   

4. Guidelines for the Use of Corticosteroids in the Treatment of Pulmonary Sarcoidosis

   • Robina K. Coker

   Therapy In Practice 18 September 2012 Pages: 1139 - 1147

   

5. Management Options for Malignant Pleural Mesothelioma

   • Ranjit K. Goudar

   Therapy In Practice 18 September 2012 Pages: 1149 - 1165

   

6. Immunosuppressive Therapy and Malignancy in Organ Transplant Recipients

   • Alex Gutierrez-Dalmau
   • Josep M. Campistol

   Review Article 18 September 2012 Pages: 1167 - 1198

   

7. Ranibizumab

   • Stephanie K. A. Blick
   • Gillian M. Keating
   • Antona J. Wagstaff

   Adis Drug Profile 18 September 2012 Pages: 1199 - 1206

   

8. Ranibizumab

   • Steven D. Schwartz

   Adis Drug Profiles 18 September 2012 Pages: 1207 - 1207

9. Ranibizumab

   • Thomas A. Ciulla

   Adis Drug Profiles 18 September 2012 Pages: 1207 - 1207

10. Ranibizumab

    • Winfried Amoaku

    Adis Drug Profile 18 September 2012 Pages: 1207 - 1209

11. Etanercept

    • Sohita Dhillon
    • Katherine A. Lyseng-Williamson
    • Lesley J. Scott

    Adis Drug Evaluation 18 September 2012 Pages: 1211 - 1241